Affymetrix Closes $73M Buy of Panomics | GenomeWeb
NEW YORK (GenomeWeb News) – Affymetrix said today that it has closed its purchase of the genetic and cellular analysis company Panomics for $73 million in cash.
 
The company said today that the addition of Panomics will enable “a more complete customer workflow, beginning with whole-genome Affymetrix microarray studies and then focusing on genes and proteins of interest with the Panomics products.” 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.